Do young women with polycystic ovary syndrome show early evidence of preclinical coronary artery disease?

Human Reproduction

Volumn 21, Issue 4, 2006, Pages 930-935

  Topcu, Semra ^a   Caliskan, Mustafa ^a   Ozcimen, Emel Ebru ^a   Tok, Derya ^a   Uckuyu, Ayla ^a   Erdogan, Dogan ^a   Gullu, Hakan ^a   Yildirir, Aylin ^a   Zeyneloglu, Hulusi ^a   Muderrisoglu, Haldun ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

Coronary artery disease; Coronary flow reserve; Polycystic ovary syndrome

Indexed keywords

ANDROSTENEDIONE; C REACTIVE PROTEIN; FOLLITROPIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LUTEINIZING HORMONE; TESTOSTERONE; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; FLOW RATE; HOMEOSTASIS; HUMAN; INSULIN BLOOD LEVEL; LABORATORY DIAGNOSIS; OVARY POLYCYSTIC DISEASE; RISK ASSESSMENT; RISK FACTOR; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TRANSTHORACIC ECHOCARDIOGRAPHY;

EID: 33645305667     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/dei431     Document Type: Article

References (41)

1. Book CB and Dunaif A (1999) Selective insulin resistance in the polycystic ovary syndrome. J Clin Endocrinol Metab 84,3110-3116.
2. Britten MB, Zeiher AM and Schachinger V (2004) Microvascular dysfunction in angiographically normal or mildly diseased coronary arteries predicts adverse cardiovascular long-term outcome. Coron Artery Dis 15, 259-264.
3. Burghen GA, Givens JR and Kitabchi AE (1980) Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease. J Clin Endocrinol Metab 50,113-116.
4. Caiati C, Montaldo C, Zedda N, Bina A and Iliceto S (1999a) New noninvasive method for coronary flow reserve assessment: contrast-enhanced transthoracic second harmonic echo Doppler. Circulation 99,771-778.
5. Caiati C, Zedda N, Montaldo C, Montisci R and Iliceto S (1999b) Contrast-enhanced transthoracic second harmonic echo Doppler with adenosine: A noninvasive, rapid and effective method for coronary flow reserve assessment. J Am Coll Cardiol 34,122-130.
6. Carmina E and Lobo RA (1999) Polycystic ovary syndrome (PCOS): Arguably the most common endocrinopathy is associated with significant morbidity in women. J Clin Endocrinol Metab 84,1897-1899.
7. Christian RC, Dumesic DA, Behrenbeck T, Oberg AL, Sheedy PF II and Fitzpatrick LA (2003) Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome. J Clin Endocrinol Metab 88,2562-2568.
8. Conway GS, Agrawal R, Betteridge DJ and Jacobs HS (1992) Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome. Clin Endocrinol (Oxf) 37,119-125.
9. Dagres N, Saller B, Haude M, Husing J, von Birgelen C, Schmermund A, Sack S, Baumgart D, Mann K and Erbel R (2004) Insulin sensitivity and coronary vasoreactivity: Insulin sensitivity relates to adenosine-stimulated coronary flow response in human subjects. Clin Endocrinol (Oxf) 61,724-731.
10. Dahlgren E, Janson PO, Johansson S, Lapidus L and Oden A (1992) Polycystic ovary syndrome and risk for myocardial infarction. Evaluated from a risk factor model based on a prospective population study of women. Acta Obstet Gynecol Scand 71,599-604.
11. Devereux RB and Reichek N (1977) Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 55,613-618.
12. Dimitrow PP (2003) Transthoracic Doppler echocardiography - noninvasive diagnostic window for coronary flow reserve assessment. Cardiovasc Ultrasound 1 (1),4.
13. Elting MW, Korsen TJ and Schoemaker J (2001) Obesity, rather than menstrual cycle pattern or follicle cohort size, determines hyperinsuIinaemia, dyslipidaemia and hypertension in ageing women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 55,767-776.
14. Galderisi M, Cicala S, Caso P, De Simone L, D'Errico A, Petrocelli A and de Divitiis O (2002) Coronary flow reserve and myocardial diastolic dysfunction in arterial hypertension. Am J Cardiol 90,860-864.
15. Galderisi M, de Simone G, Cicala S, De Simone L, D'Errico A, Caso P and de Divitiis O (2003) Coronary flow reserve in hypertensive patients with appropriate or inappropriate left ventricular mass. J Hypertens 21,2183-2188.
16. Gould KL and Lipscomb K (1974) Effects of coronary stenoses on coronary flow reserve and resistance. Am J Cardiol 34,48-55.
17. Holte J, Gennarelli G, Berne C, Bergh T and Lithell H (1996) Elevated ambulatory day-time blood pressure in women with polycystic ovary syndrome: A sign of a pre-hypertensive state? Hum Reprod 11,23-28.
18. Kaufmann PA, Gnecchi-Ruscone T, Schafers KP, Luscher TF and Camici PG (2000) Low density lipoprotein cholesterol and coronary microvascular dysfunction in hypercholesterolemia. J Am Coll Cardiol 36,103-109.
19. Laaksonen R, Janatuinen T, Vesalainen R, Lehtimaki T, Elovaara I, Jaakkola O, Jokela H, Laakso J, Nuutila P, Punnonen K, Raitakari O, Saikku P, Salminen K and Knuuti J (2002) High oxidized LDL and elevated plasma homocysteine contribute to the early reduction of myocardial flow reserve in healthy adults. Eur J Clin Invest 32,795-802.
20. Lakhani K, Seifalian AM and Hardiman P (2002) Impaired carotid viscoelastic properties in women with polycystic ovaries. Circulation 106,81-85.
21. Lambertz H, Tries HP, Stein T and Lethen H (1999) Noninvasive assessment of coronary flow reserve with transthoracic signal-enhanced Doppler echocardiography. J Am Soc Echocardiogr 12,186-195.
22. Legro RS, Kunselman AR, Dodson WC and Dunaif A (1999) Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: A prospective, controlled study in 254 affected women. J Clin Endocrinol Metab 84,165-169.
23. Legro RS, Kunselman AR and Dunaif A (2001) Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome. Am J Med 111, 607-613.
24. Mather KJ, Verma S, Corenblum B and Anderson TJ (2000) Normal endothelial function despite insulin resistance in healthy women with the polycystic ovary syndrome. J Clin Endocrinol Metab 85,1851-1856.
25. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF and Turner RC (1985) Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412-419.
26. Nitenberg A, Valensi P, Sachs R, Dali M, Aptecar E and Attali JR (1993) Impairment of coronary vascular reserve and ACh-induced coronary vasodilation in diabetic patients with angiographically normal coronary arteries and normal left ventricular systolic function. Diabetes 42,1017-1025.
27. Orio F Jr, Palomba S, Cascella T, De Simone B, Di Biase S, Russo T, Labella D, Zullo F, Lombardi G and Colao A (2004) Early impairment of endothelial structure and function in young normal-weight women with polycystic ovary syndrome. J Clin Endocrinol Metab 89,4588-4593.
28. Paradisi G, Steinberg HO, Hempfling A, Cronin J, Hook G, Shepard MK and Baron AD (2001) Polycystic ovary syndrome is associated with endothelial dysfunction. Circulation 103,1410-1415.
29. Pasquali R, Casimirri F, Cantobelli S, Labate AM, Venturoli S, Paradisi R and Zannarini L (1993) Insulin and androgen relationships with abdominal body fat distribution in women with and without hyperandrogenism. Horm Res 39,179-187.
30. Pierpoint T, McKeigue PM, Isaacs AJ, Wild SH and Jacobs HS (1998) Mortality of women with polycystic ovary syndrome at long-term follow-up. J Clin Epidemiol 51,581-586.
31. Reaven GM (1988) Banting lecture 1988: Role of insulin resistance in human disease. Diabetes 37, 1595-1607 (Review).
32. Sampson M, Kong C, Patel A, Unwin R and Jacobs HS (1996) Ambulatory blood pressure profiles and plasminogen activator inhibitor (PAI-1) activity in lean women with and without the polycystic ovary syndrome. Clin Endocrinol (Oxf) 45,623-629.
33. Strauer BE, Motz W, Vogt M and Schwartzkopff B (1997) Impaired coronary flow reserve in NIDDM: A possible role for diabetic cardiopathy in humans. Diabetes 46 (Suppl. 2),S119-S124.
34. Talbott E, Guzick D, Clerici A, Berga S, Detre K, Weimer K and Kuller L (1995) Coronary heart disease risk factors in women with polycystic ovary syndrome. Arterioscler Thromb Vasc Biol 15,821-826.
35. Talbott E, Clerici A, Berga SL, Kuller L, Guzick D, Detre K, Daniels T and Engberg RA (1998) Adverse lipid and coronary heart disease risk profiles in young women with polycystic ovary syndrome: Results of a case-control study. J Clin Epidemiol 51,415-422.
36. Talbott EO, Guzick DS, Sutton-Tyrrell K, McHugh-Pemu KP, Zborowski JV, Remsberg KE and Kuller LH (2000) Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women. Arterioscler Thromb Vasc Biol 20,2414-2421.
37. The Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop Group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19 (1), 41-47.
38. Vryonidou A, Papatheodorou A, Tavridou A, Terzi T, Loi V, Vatalas IA, Batakis N, Phenekos C and Dionyssiou-Asteriou A (2005) Association of hyperandrogenemic and metabolic phenotype with carotid intima-media thickness in young women polycystic ovary syndrome. J Clin Endocrinol Metab (Epub ahead of print).
39. Wild RA, Painter PC, Coulson PB, Carruth KB, Ranney GB (1985) Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndrome. J Clin Endocrinol Metab 61,946-951.
40. Yarali H, Yildirir A, Aybar F, Kabakci G, Bukulmez O, Akgul E and Oto A (2001) Diastolic dysfunction and increased serum homocysteine concentrations may contribute to increased cardiovascular risk in patients with polycystic ovary syndrome. Fertil Steril 76,511-516.
41. Yokoyama I, Ohtake T, Momomura S, Yonekura K, Woo-Soo S, Nishikawa J, Sasaki Y and Omata M (1998) Hyperglycemia rather than insulin resistance is related to reduced coronary flow reserve in NIDDM. Diabetes 47, 119-124.